Company Filing History:
Years Active: 1986-1990
Title: Innovator Spotlight: Karen M. McCoy – Advancing Microbial Biotechnology
Introduction
Karen M. McCoy, based in Midland, MI, is an accomplished inventor with a remarkable portfolio that includes five patents. Her work focuses on innovations in microbial biotechnology, specifically the stabilization of intracellular enzymes and the development of novel antibiotics. McCoy's contributions have significant implications for various industries, particularly in the production of antibiotics and agricultural applications.
Latest Patents
Among her latest patents, McCoy has pioneered a process for the stabilization of intracellular enzymes, specifically glucose isomerase. This invention outlines a method that involves contacting intact or ruptured microbial cells with a partially carboxyalkylated- or partially phosphonoalkylated-cationic polyelectrolyte, leading to the flocculation and stabilization of these cells. The encapsulation of the flocculated cells enhances their stability, resulting in a dramatic increase in the half-life of the glucose isomerase.
In addition, McCoy has developed antibiotics A26201-1 and A26201-2, which are produced by the novel microorganism Actinoplanes species A26201 under aqueous aerobic fermentation conditions. These antibiotics have been shown to inhibit gram-positive bacteria and promote the growth of both monogastric and ruminant animals, showcasing her innovative approach to tackling microbial resistance and enhancing animal health.
Career Highlights
Karen McCoy is currently affiliated with The Dow Chemical Company, where she applies her extensive knowledge and expertise in microbial technology towards groundbreaking innovations. Her contributions to the field have garnered recognition and respect within the scientific community, solidifying her reputation as a leading inventor.
Collaborations
Throughout her career, McCoy has worked closely with esteemed colleagues such as Roberta C. Cheng and Norman G. Moll. These collaborations have enriched her research, resulting in the development of impactful technologies and products that benefit numerous industries.
Conclusion
Karen M. McCoy continues to be a driving force in the field of microbial biotechnology, with her inventions paving the way for future developments. Through her innovative approaches and dedication to research, she has made significant contributions that will undoubtedly shape the future of antibiotic production and agricultural advancement.